ATA196378A - Verfahren zur herstellung von neuen triazinverbindungen und deren salzen - Google Patents

Verfahren zur herstellung von neuen triazinverbindungen und deren salzen

Info

Publication number
ATA196378A
ATA196378A AT196378A AT196378A ATA196378A AT A196378 A ATA196378 A AT A196378A AT 196378 A AT196378 A AT 196378A AT 196378 A AT196378 A AT 196378A AT A196378 A ATA196378 A AT A196378A
Authority
AT
Austria
Prior art keywords
salts
triazine compounds
producing new
new triazine
producing
Prior art date
Application number
AT196378A
Other languages
English (en)
Other versions
AT363952B (de
Inventor
David Hartley
Alexander William Oxford
Original Assignee
Allen & Hanburys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB12598/77A external-priority patent/GB1584461A/en
Application filed by Allen & Hanburys Ltd filed Critical Allen & Hanburys Ltd
Publication of ATA196378A publication Critical patent/ATA196378A/de
Application granted granted Critical
Publication of AT363952B publication Critical patent/AT363952B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT0196378A 1977-03-25 1978-03-20 Verfahren zur herstellung von neuen triazinverbindungen und deren salzen AT363952B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB12598/77A GB1584461A (en) 1977-03-25 1977-03-25 Imidazotriazines imidazotriazinones and pharmaceutical compositions containing them
GB4725077 1977-11-14

Publications (2)

Publication Number Publication Date
ATA196378A true ATA196378A (de) 1981-02-15
AT363952B AT363952B (de) 1981-09-10

Family

ID=26249130

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0196378A AT363952B (de) 1977-03-25 1978-03-20 Verfahren zur herstellung von neuen triazinverbindungen und deren salzen

Country Status (14)

Country Link
US (1) US4278673A (de)
JP (1) JPS53119891A (de)
AT (1) AT363952B (de)
AU (1) AU516179B2 (de)
DE (1) DE2811780A1 (de)
DK (1) DK109578A (de)
ES (1) ES468119A1 (de)
FI (1) FI780828A (de)
FR (1) FR2384773A1 (de)
IE (1) IE46653B1 (de)
IT (1) IT1105177B (de)
NL (1) NL7803195A (de)
NZ (1) NZ186699A (de)
SE (1) SE7803195L (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496927A (en) * 1985-02-04 1996-03-05 Merrell Pharmaceuticals Inc. Peptidase inhibitors
US4687776A (en) * 1986-10-24 1987-08-18 Warner-Lambert Company Drug stabilization
US4788064A (en) * 1987-07-31 1988-11-29 Warner-Lambert Company Transdermal delivery system
US5208226A (en) * 1989-09-08 1993-05-04 Glaxo Group Limited Medicaments
US5270305A (en) * 1989-09-08 1993-12-14 Glaxo Group Limited Medicaments
UA46166C2 (uk) * 1997-11-12 2002-05-15 Баєр Акцієнгезельшафт 2-фенілзаміщені імідазотриазинони як інгібітори фосфодіестерази, спосіб їх одержання та лікарський засіб на їх основі
DE19827640A1 (de) * 1998-06-20 1999-12-23 Bayer Ag 7-Alkyl- und Cycloalkyl-substituierte Imidazotriazinone
DE10063106A1 (de) * 2000-12-18 2002-06-20 Bayer Ag Verfahren zur Herstellung von 2-(2-Ethoxyphenyl)-substituierten Imidazotriazinonen
DE10064105A1 (de) 2000-12-21 2002-06-27 Bayer Ag Neue Substituierte Imidazotriazinone
CA2449163C (en) * 2001-05-09 2010-07-13 Bayer Healthcare Ag New use of 2-phenyl-substituted imidazotriazinones
US7087605B2 (en) * 2001-06-01 2006-08-08 Bayer Aktiengesellschaft 5-Ethyl-imidazotriazinones
GB0113343D0 (en) * 2001-06-01 2001-07-25 Bayer Ag Novel Heterocycles 2
GB0113344D0 (en) * 2001-06-01 2001-07-25 Bayer Ag Novel heterocycles 3
DE10130167A1 (de) * 2001-06-22 2003-01-02 Bayer Ag Imidazotriazine
DE10135815A1 (de) 2001-07-23 2003-02-06 Bayer Ag Verwendung von 2-Alkoxyphenyl-substituierten Imidazotriazinonen
GB0209988D0 (en) * 2002-05-01 2002-06-12 Bayer Ag Novel Heterocycles
GB2388111A (en) * 2002-05-01 2003-11-05 Bayer Ag Novel imidazotriazinone compounds
GB2388594A (en) * 2002-05-16 2003-11-19 Bayer Ag Imidazo-triazine PDE 4 inhibitors
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
EP1608656B1 (de) * 2003-04-01 2009-06-03 SmithKline Beecham Corporation Imidazotriazin verbindungen zur behandlung von krebserkrankungen
JP2008501617A (ja) * 2004-06-11 2008-01-24 アスビオファーマ株式会社 Ｐｄｅ７阻害作用を有するイミダゾトリアジノン誘導体
US8603631B2 (en) * 2004-10-13 2013-12-10 Knauf Insulation Gmbh Polyester binding compositions
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
AU2006299232A1 (en) * 2005-09-29 2007-04-12 Bayer Schering Pharma Aktiengesellschaft PDE inhibitors and combinations thereof for the treatment of urological disorders
DE102006048693A1 (de) * 2006-10-14 2008-04-17 Bayer Healthcare Ag Inhibition der PDE2A
WO2008151734A1 (en) * 2007-06-13 2008-12-18 Bayer Schering Pharma Aktiengesellschaft Pde inhibitors for the treatment of hearing impairment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791025A (fr) * 1971-11-19 1973-05-07 Allen & Hanburys Ltd Composes heterocycliques
GB1457873A (en) * 1973-01-04 1976-12-08 Allen & Hanburys Ltd Imidazotriazines

Also Published As

Publication number Publication date
FI780828A (fi) 1978-09-26
IT1105177B (it) 1985-10-28
ES468119A1 (es) 1979-09-01
US4278673A (en) 1981-07-14
DK109578A (da) 1978-09-26
NZ186699A (en) 1980-12-19
AU3431478A (en) 1979-09-27
AT363952B (de) 1981-09-10
IE780625L (en) 1978-09-25
JPS53119891A (en) 1978-10-19
FR2384773B1 (de) 1980-07-04
IT7848546A0 (it) 1978-03-22
IE46653B1 (en) 1983-08-10
FR2384773A1 (fr) 1978-10-20
SE7803195L (sv) 1978-09-26
AU516179B2 (en) 1981-05-21
DE2811780A1 (de) 1978-09-28
NL7803195A (nl) 1978-09-27

Similar Documents

Publication Publication Date Title
AT363952B (de) Verfahren zur herstellung von neuen triazinverbindungen und deren salzen
ATA601078A (de) Verfahren zur herstellung von neuen nitro- imidazolen und von deren salzen
AT364851B (de) Verfahren zur herstellung von neuen thienothiazinderivaten und von deren salzen
AT363491B (de) Verfahren zur herstellung von neuen 1,3,8trisubstituierten xanthinen und deren salzen
AT371454B (de) Verfahren zur herstellung von neuen prostanderivaten und von deren salzen
AT366043B (de) Verfahren zur herstellung von neuen chinazolinderivaten und deren salzen
ATA204479A (de) Verfahren zur herstellung von neuen n-oxacyclyl- alkyl-piperidyl-daizaverbindungen und von deren salzen
AT365188B (de) Verfahren zur herstellung von neuen 7-azabenzimidazolen und deren salzen
AT371112B (de) Verfahren zur herstellung von neuen 2-imino-imidazolidin-derivaten und von deren salzen
AT363937B (de) Verfahren zur herstellung von neuen bispidinderivaten und deren salzen
ATA747378A (de) Verfahren zur herstellung von neuen 1-aryl-alkyl-imidazolderivaten und deren salzen
AT362355B (de) Verfahren zur herstellung von neuen dithienyl (3)-verbindungen und deren salzen
ATA57578A (de) Verfahren zur herstellung von neuen azacycloalkanen und azacycloalkenen und deren derivaten und salzen
AT367410B (de) Verfahren zur herstellung von neuen 2-benzazepin- verbindungen und deren salzen
AT360999B (de) Verfahren zur herstellung von neuen amidino- -benzylpyrimidinen und deren salzen
AT359070B (de) Verfahren zur herstellung von neuen 2,4-diamino -5-benzylpyrimidinen und deren salzen
AT365183B (de) Verfahren zur herstellung von neuen 4-amino-2-piperidinochinazolinderivaten und deren salzen
AT358050B (de) Verfahren zur herstellung von neuen triazolo- thieno-diazepin-1-onen und deren salzen
ATA320578A (de) Verfahren zur herstellung von neuen benzylpyrimidinen und deren salzen
ATA73877A (de) Verfahren zur herstellung von neuen oxadiazolopyrimidinderivaten und von deren salzen
AT366665B (de) Verfahren zur herstellung von neuen n-isothioureido-phthalimiden und deren salzen
ATA356778A (de) Verfahren zur herstellung von neuen 4-hydroxy- thiazolidin-2-thion-derivaten und von deren salzen
AT374459B (de) Verfahren zur herstellung von neuen pyridinverbindungen und deren salzen
ATA614779A (de) Verfahren zur herstellung von neuen triazolo- -thieno-diazepin-1-onen und deren salzen
ATA491181A (de) Verfahren zur herstellung von neuen pyridinund phyrimidinverbindungen und deren salzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
UEP Publication of translation of european patent specification